Somayeh Pouyanfard

Somayeh Pouyanfard is a Senior Scientist and Team Lead at Fate Therapeutics Inc, specializing in the development of off-the-shelf iPSC-derived CAR-T, CAR-NK, and CAR-Macrophage cell therapeutics since 2022. Additionally, Somayeh holds a Senior Scientist position at Wugen, where expertise in CAR-NK, CAR-Macrophage, and CAR-T cell therapeutics has been applied since May 2021. Prior experience includes a Postdoctoral Researcher role at the University of California San Diego focused on novel cell therapeutics for cancer and regenerative medicine from August 2017 to May 2021, and at DKFZ German Cancer Research Center, where Somayeh worked on a novel prophylactic vaccine for cervical cancer from September 2014 to July 2017. A Visiting Researcher position at the University of Zurich involved developing delivery platforms for cancer-targeting drugs during 2012 to 2013.